{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T22:44:17Z","timestamp":1773441857681,"version":"3.50.1"},"reference-count":83,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,2,16]],"date-time":"2023-02-16T00:00:00Z","timestamp":1676505600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Drug Saf. Regul."],"abstract":"<jats:p>Pain management has been a challenging issue for people living with rheumatic and musculoskeletal diseases (RMDs) and health professionals for decades. Pharmacological treatments remain a core element of pain management of inflammatory arthritis and osteoarthritis. Yet balancing the benefits\/harms in pain management within RMDs can be difficult to navigate due to limited effective options, and emerging adverse events in a population where individual risk is important to consider due to patient multimorbidity, immunosuppression and polypharmacy. Paracetamol and non-steroidal anti-inflammatory drugs (NSAIDs) analgesics are widely used among RMD patients, however both classes of drugs have been associated with new safety concerns in the last two decades. Perhaps as a result in combination with multifactorial influences, opioid prescribing has increased from the 2000s\u20132010s in the majority of RMD focussed studies, accompanied with a rising trend of long-term opioid use, despite limited evidence on efficacy. Gabapentinoids have also shown increasing trends more recently, despite an unclear role in chronic pain management for RMDs within current guidelines. Antidepressants are recommended as the first line of pharmacological treatment of chronic primary pain (e.g., fibromyalgia) by the latest National Institute for Health and Care Excellence (NICE) guideline released in April 2021. This concise narrative review will discuss pharmacological options for pain management, based on the latest evidence that includes the main analgesic drug classes: paracetamol, NSAIDs, opioids, antidepressants, and gabapentinoids. We will discuss the efficacy of these analgesics in RMDs and emerging safety concerns to enable more informed shared decisions with patients commencing such medications.<\/jats:p>","DOI":"10.3389\/fdsfr.2023.1117674","type":"journal-article","created":{"date-parts":[[2023,2,16]],"date-time":"2023-02-16T10:51:19Z","timestamp":1676544679000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":7,"title":["Balancing the evidence: An update on analgesic use in rheumatic and musculoskeletal diseases"],"prefix":"10.3389","volume":"3","author":[{"given":"Yun-Ting","family":"Huang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Craig","family":"McCarthy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meghna","family":"Jani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2023,2,16]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"324","DOI":"10.5694\/mja2.50992","article-title":"The efficacy and safety of paracetamol for pain relief: An overview of systematic reviews","volume":"214","author":"Abdel Shaheed","year":"2021","journal-title":"Med. J. Aust."},{"key":"B2","doi-asserted-by":"publisher","first-page":"i1","DOI":"10.1093\/ageing\/afs200","article-title":"Guidance on the management of pain in older people","volume":"42","author":"Abdulla","year":"2013","journal-title":"Age Ageing"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1111\/j.1532-5415.2009.02376.x","article-title":"Pharmacological management of persistent pain in older persons","volume":"57","year":"2009","journal-title":"J. Am. Geriatrics Soc."},{"key":"B4","first-page":"670","article-title":"Opioid overdose hospitalizations in patients with systemic lupus erythematosus and rheumatoid arthritis","volume":"71","author":"Anastasiou","year":"2019","journal-title":"Arthritis Rheumatol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1097\/BOR.0000000000000868","article-title":"Review of publications evaluating opioid use in patients with inflammatory rheumatic disease","volume":"34","author":"Anastasiou","year":"2022","journal-title":"Curr. Opin. Rheumatol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1634","DOI":"10.1161\/CIRCULATIONAHA.106.181424","article-title":"Use of nonsteroidal antiinflammatory drugs: An update for clinicians: A scientific statement from the American heart association","volume":"115","author":"Antman","year":"2007","journal-title":"Circulation"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1097\/j.pain.0000000000000554","article-title":"A randomized controlled trial of gabapentin for chronic low back pain with and without a radiating component","volume":"157","author":"Atkinson","year":"2016","journal-title":"Pain"},{"key":"B8","doi-asserted-by":"publisher","first-page":"j1909","DOI":"10.1136\/bmj.j1909","article-title":"Risk of acute myocardial infarction with NSAIDs in real world use: Bayesian meta-analysis of individual patient data","volume":"357","author":"Bally","year":"2017","journal-title":"Bmj"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1016\/j.joca.2019.06.011","article-title":"OARSI guidelines for the non-surgical management of knee, hip, and polyarticular osteoarthritis","volume":"27","author":"Bannuru","year":"2019","journal-title":"Osteoarthr. Cartil."},{"key":"B10","doi-asserted-by":"publisher","first-page":"879","DOI":"10.18553\/jmcp.2019.25.8.879","article-title":"Health care effect of disease-modifying antirheumatic drug use on patients with rheumatoid arthritis","volume":"25","author":"Boytsov","year":"2019","journal-title":"J. Manag. Care Spec. Pharm."},{"key":"B11","doi-asserted-by":"publisher","first-page":"2448","DOI":"10.1001\/jama.2018.18472","article-title":"Opioids for chronic noncancer pain: A systematic review and meta-analysis","volume":"320","author":"Busse","year":"2018","journal-title":"JAMA"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.3109\/10641968409039582","article-title":"Effects of indomethacin, sulindac, naproxen, aspirin, and paracetamol in treated hypertensive patients","volume":"6","author":"Chalmers","year":"1984","journal-title":"Clin. Exp. Hypertens. A"},{"key":"B13","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1016\/S0140-6736(17)30981-9","article-title":"Gastrointestinal safety of celecoxib versus naproxen in patients with cardiothrombotic diseases and arthritis after upper gastrointestinal bleeding (CONCERN): An industry-independent, double-blind, double-dummy, randomised trial","volume":"389","author":"Chan","year":"2017","journal-title":"Lancet"},{"key":"B14","doi-asserted-by":"publisher","first-page":"480","DOI":"10.7326\/M16-2458","article-title":"Systemic pharmacologic therapies for low back pain: A systematic review for an American College of physicians clinical practice guideline","volume":"166","author":"Chou","year":"2017","journal-title":"Ann. Intern Med."},{"key":"B15","doi-asserted-by":"publisher","first-page":"276","DOI":"10.7326\/M14-2559","article-title":"The effectiveness and risks of long-term opioid therapy for chronic pain: A systematic review for a national institutes of health pathways to prevention workshop","volume":"162","author":"Chou","year":"2015","journal-title":"Ann. Intern. Med."},{"key":"B16","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1136\/annrheumdis-2016-210602","article-title":"2016 update of the EULAR recommendations for the management of early arthritis","volume":"76","author":"Combe","year":"2016","journal-title":"Ann. Rheum. Dis."},{"key":"B17","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1093\/rheumatology\/kep005","article-title":"Cardiovascular safety and gastrointestinal tolerability of etoricoxib vs diclofenac in a randomized controlled clinical trial (The MEDAL study)","volume":"48","author":"Combe","year":"2009","journal-title":"Rheumatol. Oxf."},{"key":"B18","doi-asserted-by":"publisher","first-page":"2204","DOI":"10.1001\/archinte.162.19.2204","article-title":"Frequency of analgesic use and risk of hypertension in younger women","volume":"162","author":"Curhan","year":"2002","journal-title":"Arch. Intern Med."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1097\/HJH.0b013e328360f6f8","article-title":"Acetaminophen use and change in blood pressure in a hypertensive population","volume":"31","author":"Dawson","year":"2013","journal-title":"J. Hypertens."},{"key":"B20","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1161\/01.hyp.0000035856.77718","article-title":"Nonnarcotic analgesic use and the risk of hypertension in US women","volume":"40","author":"Dedier","year":"2002","journal-title":"Hypertension"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1534","DOI":"10.1136\/ard.2011.154047","article-title":"A randomised controlled trial of ibuprofen, paracetamol or a combination tablet of ibuprofen\/paracetamol in community-derived people with knee pain","volume":"70","author":"Doherty","year":"2011","journal-title":"Ann. Rheum. Dis."},{"key":"B22","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1016\/S0140-6736(13)60900-9","article-title":"Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials","volume":"382","author":"Emberson","year":"2013","journal-title":"Lancet"},{"key":"B23","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1007\/s12325-014-0128-6","article-title":"Safety and tolerability of tapentadol extended release in moderate to severe chronic osteoarthritis or low back pain management: Pooled analysis of randomized controlled trials","volume":"31","author":"Etropolski","year":"2014","journal-title":"Adv. Ther."},{"key":"B24","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/s40265-020-01432-7","article-title":"Abuse and misuse of pregabalin and gabapentin: A systematic review update","volume":"81","author":"Evoy","year":"2021","journal-title":"Drugs"},{"key":"B25","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s13643-021-01599-4","article-title":"Efficacy, acceptability, and safety of antidepressants for low back pain: A systematic review and meta-analysis","volume":"10","author":"Ferraro","year":"2021","journal-title":"Syst. Rev."},{"key":"B26","doi-asserted-by":"publisher","first-page":"m4825","DOI":"10.1136\/bmj.m4825","article-title":"Efficacy and safety of antidepressants for the treatment of back pain and osteoarthritis: Systematic review and meta-analysis","volume":"372","author":"Ferreira","year":"2021","journal-title":"Bmj"},{"key":"B27","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1001\/archinte.167.4.394","article-title":"Frequency of analgesic use and risk of hypertension among men","volume":"167","author":"Forman","year":"2007","journal-title":"Arch. Intern Med."},{"key":"B28","doi-asserted-by":"publisher","first-page":"3420","DOI":"10.3390\/jcm10153420","article-title":"Paracetamol: A review of guideline recommendations","volume":"10","author":"Freo","year":"2021","journal-title":"J. Clin. Med."},{"key":"B29","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/1471-2288-9-35","article-title":"Estimating the number needed to treat from continuous outcomes in randomised controlled trials: Methodological challenges and worked example using data from the UK back pain exercise and manipulation (BEAM) trial","volume":"9","author":"Froud","year":"2009","journal-title":"BMC Med. Res. Methodol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1097\/00001648-200109000-00018","article-title":"Relative risk of upper gastrointestinal complications among users of acetaminophen and nonsteroidal anti-inflammatory drugs","volume":"12","author":"Garc\u00eda Rodr\u00edguez","year":"2001","journal-title":"Epidemiology"},{"key":"B31","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1111\/j.1742-7843.2006.pto_248.x","article-title":"Upper gastrointestinal complications among users of paracetamol","volume":"98","author":"Gonz\u00e1lez-P\u00e9rez","year":"2006","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1161\/STROKEAHA.115.012091","article-title":"Paracetamol, ibuprofen, and recurrent major cardiovascular and major bleeding events in 19 120 patients with recent ischemic stroke","volume":"47","author":"Gonzalez-Valcarcel","year":"2016","journal-title":"Stroke"},{"key":"B33","doi-asserted-by":"publisher","first-page":"297","DOI":"10.2165\/11598970-000000000-00000","article-title":"The role of antidepressants in the management of fibromyalgia syndrome: A systematic review and meta-analysis","volume":"26","author":"Hauser","year":"2012","journal-title":"CNS Drugs"},{"key":"B34","doi-asserted-by":"publisher","first-page":"1937","DOI":"10.2147\/JPR.S168188","article-title":"Nonsteroidal anti-inflammatory drugs in chronic pain: Implications of new data for clinical practice","volume":"11","author":"Ho","year":"2018","journal-title":"J. Pain Res."},{"key":"B35","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1016\/j.spinee.2011.03.017","article-title":"Real-world practice patterns, health-care utilization, and costs in patients with low back pain: The long road to guideline-concordant care","volume":"11","author":"Ivanova","year":"2011","journal-title":"Spine J."},{"key":"B36","doi-asserted-by":"publisher","first-page":"e1003270","DOI":"10.1371\/journal.pmed.1003270","article-title":"Time trends and prescribing patterns of opioid drugs in UK primary care patients with non-cancer pain: A retrospective cohort study","volume":"17","author":"Jani","year":"2020","journal-title":"PLoS Med."},{"key":"B37","doi-asserted-by":"publisher","first-page":"e1003829","DOI":"10.1371\/journal.pmed.1003829","article-title":"Opioid prescribing among new users for non-cancer pain in the USA, Canada, UK, and taiwan: A population-based cohort study","volume":"18","author":"Jani","year":"2021","journal-title":"PLoS Med."},{"key":"B38","doi-asserted-by":"publisher","first-page":"3315","DOI":"10.1017\/S0033291716002099","article-title":"Recent trends in primary-care antidepressant prescribing to children and young people: An e-cohort study","volume":"46","author":"John","year":"2016","journal-title":"Psychol. Med."},{"key":"B39","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.pain.2004.09.019","article-title":"Opioids in chronic non-cancer pain: Systematic review of efficacy and safety","volume":"112","author":"Kalso","year":"2004","journal-title":"Pain"},{"key":"B40","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1007\/s40261-022-01139-5","article-title":"Efficacy and safety of tramadol hydrochloride twice-daily sustained-release bilayer tablets with an immediate-release component for chronic pain associated with knee osteoarthritis: A randomized, double-blind, placebo-controlled, treatment-withdrawal study","volume":"42","author":"Kawai","year":"2022","journal-title":"Clin. Drug Investig."},{"key":"B41","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1016\/j.semarthrit.2018.07.003","article-title":"Delay in initiation of DMARD or anti-inflammatory therapy in patients newly diagnosed with rheumatoid arthritis: An analysis of United States Military Health System TRICARE beneficiaries","volume":"48","author":"Kimsey","year":"2019","journal-title":"Semin. Arthritis Rheum."},{"key":"B42","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1002\/art.41142","article-title":"2019 American College of rheumatology\/arthritis foundation guideline for the management of osteoarthritis of the hand, hip, and knee","volume":"72","author":"Kolasinski","year":"2019","journal-title":"Arthritis rheumatol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1001\/jama.2018.0899","article-title":"Effect of opioid vs nonopioid medications on pain-related function in patients with chronic back pain or hip or knee osteoarthritis pain: The SPACE randomized clinical trial","volume":"319","author":"Krebs","year":"2018","journal-title":"JAMA"},{"key":"B44","doi-asserted-by":"publisher","first-page":"2387","DOI":"10.1001\/jama.2022.10100","article-title":"Gabapentin increasingly implicated in overdose deaths","volume":"327","author":"Kuehn","year":"2022","journal-title":"JAMA"},{"key":"B45","doi-asserted-by":"publisher","first-page":"1903","DOI":"10.1001\/archinte.165.16.1903","article-title":"Analgesic use and risk of subsequent hypertension in apparently healthy men","volume":"165","author":"Kurth","year":"2005","journal-title":"Arch. Intern Med."},{"key":"B46","doi-asserted-by":"publisher","first-page":"CD013273","DOI":"10.1002\/14651858.CD013273","article-title":"Paracetamol versus placebo for knee and hip osteoarthritis","volume":"2","author":"Leopoldino","year":"2019","journal-title":"Cochrane Database Syst. Rev."},{"key":"B47","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1136\/bmj.292.6525.934-a","article-title":"Effects of indomethacin and sulindac on blood pressure of hypertensive patients","volume":"292","author":"Lewis","year":"1986","journal-title":"Br. Med. J. Clin. Res. Ed."},{"key":"B48","first-page":"24","article-title":"Recognizing the risks of chronic nonsteroidal anti-inflammatory drug use in older adults","volume":"18","author":"Marcum","year":"2010","journal-title":"Ann. Longterm Care"},{"key":"B49","doi-asserted-by":"publisher","first-page":"2218","DOI":"10.1111\/bcp.13656","article-title":"Long-term adverse effects of paracetamol - a review","volume":"84","author":"McCrae","year":"2018","journal-title":"Br. J. Clin. Pharmacol."},{"key":"B50","unstructured":"Diclofenac: New contraindications and warnings 20142014"},{"key":"B51","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/j.jpain.2017.12.001","article-title":"Efficacy and safety of oral and transdermal opioid analgesics for musculoskeletal pain in older adults: A systematic review of randomized, placebo-controlled trials","volume":"19","author":"Megale","year":"2018","journal-title":"J. Pain"},{"key":"B52","unstructured":"Safety and efficacy considerations for chronic use of NSAIDs for chronic Pain2020\n            MeiJ.\n            PolyakovaO.\n            DhaliwallS.\n            McDonaldK.\n            WongA. Y.\n          2020"},{"key":"B53","doi-asserted-by":"publisher","first-page":"Cd007938","DOI":"10.1002\/14651858.CD007938.pub2","article-title":"Gabapentin for chronic neuropathic pain and fibromyalgia in adults","volume":"2014","author":"Moore","year":"2014","journal-title":"Cochrane Database Syst. Rev."},{"key":"B54","unstructured":"Chronic pain (primary and secondary) in over 16s: Assessment of all chronic pain and management of chronic primary pain 2021"},{"key":"B55","unstructured":"Hypertension in adults: Diagnosis and management 20192019"},{"key":"B56","unstructured":"Medicines associated with dependence or withdrawal symptoms: Safe prescribing and withdrawal management for adults 2022"},{"key":"B57","unstructured":"Osteoarthritis in over 16s: Diagnosis and management 2022"},{"key":"B58","unstructured":"Rheumatoid arthritis in adults: Management2018"},{"key":"B59","unstructured":"Shared decision making 2021"},{"key":"B60","unstructured":"Low back pain and sciatica in over 16s: Assessment and management 20162016"},{"key":"B61","doi-asserted-by":"publisher","first-page":"2519","DOI":"10.1056\/NEJMoa1611593","article-title":"Cardiovascular safety of celecoxib, naproxen, or ibuprofen for arthritis","volume":"375","author":"Nissen","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"B62","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1097\/j.pain.0000000000002423","article-title":"Efficacy and safety of strong opioids for chronic noncancer pain and chronic low back pain: A systematic review and meta-analyses","volume":"163","author":"Nury","year":"2022","journal-title":"Pain"},{"key":"B63","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1136\/annrheumdis-2019-215328","article-title":"Medications associated with fracture risk in patients with rheumatoid arthritis","volume":"78","author":"Ozen","year":"2019","journal-title":"Ann. Rheum. Dis."},{"key":"B64","doi-asserted-by":"publisher","first-page":"628","DOI":"10.7326\/0003-4819-107-5-628","article-title":"Ibuprofen interferes with the efficacy of antihypertensive drugs. A randomized, double-blind, placebo-controlled trial of ibuprofen compared with acetaminophen","volume":"107","author":"Radack","year":"1987","journal-title":"Ann. Intern Med."},{"key":"B65","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1111\/j.1572-0241.2008.01811.x","article-title":"Hospitalizations for upper and lower GI events associated with traditional NSAIDs and acetaminophen among the elderly in Quebec, Canada","volume":"103","author":"Rahme","year":"2008","journal-title":"Am. J. Gastroenterol."},{"key":"B66","doi-asserted-by":"publisher","first-page":"Cd012230","DOI":"10.1002\/14651858.CD012230","article-title":"Paracetamol for low back pain","volume":"2016","author":"Saragiotto","year":"2016","journal-title":"Cochrane Database Syst. Rev."},{"key":"B67","doi-asserted-by":"publisher","first-page":"k3426","DOI":"10.1136\/bmj.k3426","article-title":"Diclofenac use and cardiovascular risks: Series of nationwide cohort studies","volume":"362","author":"Schmidt","year":"2018","journal-title":"Bmj"},{"key":"B68","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1080\/03007995.2017.1335189","article-title":"Tapentadol prolonged-release for moderate-to-severe chronic osteoarthritis knee pain: A double-blind, randomized, placebo- and oxycodone controlled release-controlled study","volume":"33","author":"Serrie","year":"2017","journal-title":"Curr. Med. Res. Opin."},{"key":"B69","doi-asserted-by":"publisher","first-page":"E578","DOI":"10.1097\/BRS.0b013e3181d3cef6","article-title":"Efficacy and safety of duloxetine in patients with chronic low back pain","volume":"35","author":"Skljarevski","year":"1976","journal-title":"Spine (Phila Pa"},{"key":"B70","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1111\/j.1468-1331.2009.02648.x","article-title":"A double-blind, randomized trial of duloxetine versus placebo in the management of chronic low back pain","volume":"16","author":"Skljarevski","year":"2009","journal-title":"Eur. J. Neurol."},{"key":"B71","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.medcli.2015.09.022","article-title":"Appropriate prescription, adherence and safety of non-steroidal anti-inflammatory drugs","volume":"146","author":"Sostres","year":"2016","journal-title":"Med. Clin. Barc."},{"key":"B72","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1161\/CIRCULATIONAHA.110.956490","article-title":"Acetaminophen increases blood pressure in patients with coronary artery disease","volume":"122","author":"Sudano","year":"2010","journal-title":"Circulation"},{"key":"B73","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1016\/S0140-6736(19)32042-2","article-title":"NICE hypertension guidelines: A pragmatic compromise","volume":"394","year":"2019","journal-title":"Lancet"},{"key":"B74","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.bja.2020.05.017","article-title":"Trends in gabapentinoid prescribing, co-prescribing of opioids and benzodiazepines, and associated deaths in Scotland","volume":"125","author":"Torrance","year":"2020","journal-title":"Br. J. Anaesth."},{"key":"B75","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1111\/bcp.12032","article-title":"A systematic review of the effect of paracetamol on blood pressure in hypertensive and non-hypertensive subjects","volume":"75","author":"Turtle","year":"2013","journal-title":"Br. J. Clin. Pharmacol."},{"key":"B76","doi-asserted-by":"publisher","first-page":"n80","DOI":"10.1136\/bmj.n80","article-title":"Antidepressants for musculoskeletal pain","volume":"372","author":"Underwood","year":"2021","journal-title":"Bmj"},{"key":"B77","unstructured":"COX-2 selective (includes bextra, celebrex, and vioxx) and non-selective non-steroidal anti-inflammatory drugs (NSAIDs) 20182018"},{"key":"B78","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1136\/annrheumdis-2016-210770","article-title":"2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritis","volume":"76","author":"van der Heijde","year":"2016","journal-title":"Ann. Rheum. Dis."},{"key":"B79","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1001\/jama.2012.193412","article-title":"Opioid analgesics for rheumatoid arthritis pain","volume":"309","author":"Whittle","year":"2013","journal-title":"JAMA"},{"key":"B80","doi-asserted-by":"publisher","first-page":"Cd003113","DOI":"10.1002\/14651858.CD003113.pub3","article-title":"Opioid therapy for treating rheumatoid arthritis pain","volume":"11","author":"Whittle","year":"2011","journal-title":"Cochrane Database Syst. Rev."},{"key":"B81","volume-title":"World health organization model list of essential medicines, 21st list","year":"20192023"},{"key":"B82","doi-asserted-by":"publisher","first-page":"CD007938","DOI":"10.1002\/14651858.CD007938.pub4","article-title":"Gabapentin for chronic neuropathic pain in adults","volume":"6","author":"Wiffen","year":"2017","journal-title":"Cochrane Database Syst. Rev."},{"key":"B83","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1002\/pds.3463","article-title":"Trends in the use of aspirin and nonsteroidal anti-inflammatory drugs in the general U.S. population","volume":"23","author":"Zhou","year":"2014","journal-title":"Pharmacoepidemiol Drug Saf."}],"container-title":["Frontiers in Drug Safety and Regulation"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fdsfr.2023.1117674\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,21]],"date-time":"2024-11-21T14:22:30Z","timestamp":1732198950000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fdsfr.2023.1117674\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,16]]},"references-count":83,"alternative-id":["10.3389\/fdsfr.2023.1117674"],"URL":"https:\/\/doi.org\/10.3389\/fdsfr.2023.1117674","relation":{},"ISSN":["2674-0869"],"issn-type":[{"value":"2674-0869","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,16]]},"article-number":"1117674"}}